$15M Bet On Day One Biopharmaceuticals? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insider trades were noted in three US-listed companies: Day One Biopharmaceuticals, Central Securities Corporation, and RE/MAX Holdings. Day One Biopharmaceuticals' 10% owner Len Blavatnik acquired 1,475,454 shares at an average price of $10.15, costing around $14.98 million. Central Securities Corporation's Vice President Andrew J. O'Neill acquired 1,954 shares at an average price of $35.80, costing around $69,947. RE/MAX Holdings' 10% owner Magnolia Group LLC bought 15,000 shares at an average price of $10.74, costing around $161,100.
October 23, 2023 | 10:44 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Central Securities Corporation's Vice President Andrew J. O'Neill made an insider purchase.
Insider purchases often indicate confidence in the company's prospects, potentially leading to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Day One Biopharmaceuticals saw a significant insider purchase by 10% owner Len Blavatnik.
Insider purchases often indicate confidence in the company's prospects, potentially leading to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
RE/MAX Holdings' 10% owner Magnolia Group LLC made an insider purchase.
Insider purchases often indicate confidence in the company's prospects, potentially leading to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100